Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis?

Z Sieglova, S Zilovcova, J Cermak, H Rihova, D Brezinova, R Dvorakova, M Markova, J Maaloufova, J Sajdova, J Brezinova, Z Zemanova, K Michalova

. 2004 ; 28 (10) : 1013-1021.

Jazyk angličtina Země Velká Británie

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13007275

Grantová podpora
NC7606 MZ0 CEP - Centrální evidence projektů
NK7713 MZ0 CEP - Centrální evidence projektů

Telomere length was evaluated by terminal repeat fragment method (TRF) in 50 patients with myelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML) arising from MDS and in 21 patients with untreated primary AML to ascertain, whether telomere erosion was associated with progression of MDS towards overt leukemia. Heterogeneity of TRF among MDS FAB subgroups (P=0.004) originated from its shortening in increased number of patients during progression of the disease. Chromosomal aberrations were present in 32% MDS patients with more eroded telomeres (P=0.022), nevertheless a difference between mean TRF in the subgroups with normal and abnormal karyotype diminished during progression of MDS. A negative correlation between individual TRF and IPSS value (P=0.039) showed that telomere dynamics might serve as a useful prognostic factor for assessment of an individual MDS patient's risk and for decision of an optimal treatment strategy.

Citace poskytuje Crossref.org

Obsahuje tabulky.

000      
00000naa a2200000 a 4500
001      
bmc13007275
003      
CZ-PrNML
005      
20250121111740.0
007      
ta
008      
130221s2004 xxkdf f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.leukres.2003.11.020 $2 doi
035    __
$a (PubMed)15289012
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xxk
100    1_
$a Sieglová, Zuzana, $7 xx0053137 $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, Prague, Czech Republic. sieglova@uhkt.cz $d 1946-
245    10
$a Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis? / $c Z Sieglova, S Zilovcova, J Cermak, H Rihova, D Brezinova, R Dvorakova, M Markova, J Maaloufova, J Sajdova, J Brezinova, Z Zemanova, K Michalova
500    __
$a Obsahuje tabulky.
520    9_
$a Telomere length was evaluated by terminal repeat fragment method (TRF) in 50 patients with myelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML) arising from MDS and in 21 patients with untreated primary AML to ascertain, whether telomere erosion was associated with progression of MDS towards overt leukemia. Heterogeneity of TRF among MDS FAB subgroups (P=0.004) originated from its shortening in increased number of patients during progression of the disease. Chromosomal aberrations were present in 32% MDS patients with more eroded telomeres (P=0.022), nevertheless a difference between mean TRF in the subgroups with normal and abnormal karyotype diminished during progression of MDS. A negative correlation between individual TRF and IPSS value (P=0.039) showed that telomere dynamics might serve as a useful prognostic factor for assessment of an individual MDS patient's risk and for decision of an optimal treatment strategy.
650    02
$a mladiství $7 D000293
650    02
$a dospělí $7 D000328
650    02
$a senioři $7 D000368
650    02
$a senioři nad 80 let $7 D000369
650    02
$a dítě $7 D002648
650    02
$a chromozomální aberace $7 D002869
650    02
$a progrese nemoci $7 D018450
650    12
$a nestabilita genomu $7 D042822
650    02
$a lidé $7 D006801
650    02
$a karyotypizace $7 D007621
650    12
$a akutní myeloidní leukemie $x diagnóza $x genetika $7 D015470
650    02
$a lidé středního věku $7 D008875
650    12
$a myelodysplastické syndromy $x diagnóza $7 D009190
650    02
$a prognóza $7 D011379
650    02
$a rizikové faktory $7 D012307
650    12
$a telomery $x genetika $7 D016615
650    12
$a nádorové biomarkery $x genetika $7 D014408
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Včelíková, Soňa $7 xx0149005 $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, Prague, Czech Republic
700    1_
$a Čermák, Jaroslav, $7 xx0053072 $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, Prague, Czech Republic $d 1954-
700    1_
$a Žižková, Hana $7 xx0143836 $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, Prague, Czech Republic
700    1_
$a Březinová, Dagmar $7 xx0327825 $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, Prague, Czech Republic
700    1_
$a Dvořáková, Renáta $7 xx0077642 $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, Prague, Czech Republic
700    1_
$a Marková, Markéta $7 xx0101281 $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, Prague, Czech Republic
700    1_
$a Maaloufová, Jacqueline $7 xx0064317 $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, Prague, Czech Republic
700    1_
$a Sajdová, Jana $7 xx0098121 $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, Prague, Czech Republic
700    1_
$a Březinová, Jana, $d 1958- $7 xx0046958
700    1_
$a Zemanová, Zuzana, $d 1962- $7 nlk20050170627
700    1_
$a Michalová, Kyra, $d 1942- $7 nlk19990073558
773    0_
$t Leukemia Research $x 0145-2126 $g Roč. 28, č. 10 (2004), s. 1013-1021 $p Leuk Res $w MED00003141
910    __
$a ABA008 $y 4 $z 0
990    __
$a 20130221160114 $b ABA008
991    __
$a 20250121111737 $b ABA008
999    __
$a ok $b bmc $g 970265 $s 805510
BAS    __
$a 3
BMC    __
$a 2004 $b 28 $c 10 $d 1013-1021 $i 0145-2126 $m Leukemia research $x MED00003141 $n Leuk Res
GRA    __
$a NC7606 $p MZ0
GRA    __
$a NK7713 $p MZ0
LZP    __
$c NLK110 $d 20130222 $a NLK 2013-02/lp
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace